awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36673751-FB6821B6-F368-42B3-94E8-1E8D8F99CAA2
Q36673751-FB6821B6-F368-42B3-94E8-1E8D8F99CAA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-FB6821B6-F368-42B3-94E8-1E8D8F99CAA2
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
P2860
Q36673751-FB6821B6-F368-42B3-94E8-1E8D8F99CAA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-FB6821B6-F368-42B3-94E8-1E8D8F99CAA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80ea7c2cf7e7344ab33e97426c8f36d9e11982d8
P2860
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer